Lytic Cycle of Bacteriophages: Viral Replication Steps Explained

Bacterial restriction-modification systems protect against viral DNA by methylating bacterial DNA and cutting unmethylated viral DNA. CRISPR spacers are acquired from viral DNA upon first infection, creating a memory of encountered viruses. This adaptive immunity allows bacteria to recognize and destroy specific viruses upon re-infection, analogous to vertebrate adaptive immunity.

Bacteria use a restriction modification system as an immune defense mechanism against viral attacks. The system involves two key components: restriction enzymes that cut DNA at specific recognition sites, and methyltransferase enzymes that add methyl groups to the bacterium's own DNA at these same sites. When viral DNA enters the bacterium, it lacks these methyl groups, allowing restriction enzymes to recognize and cut the viral DNA, thereby destroying it and protecting the bacterial cell.

Bacteria possess restriction-modification systems that distinguish self from non-self DNA through methylation patterns. Methyltransferases modify host DNA at specific sequences, while restriction enzymes cut unmethylated viral DNA. Bacteria also employ toxin-antitoxin systems where antitoxins neutralize toxins; viral infection disrupts protein synthesis, causing antitoxin depletion and triggering cell death to protect the colony. Bacteria possess CRISPR-Cas systems providing adaptive immunity against viruses. Unique spacer sequences between repetitive DNA elements serve as molecular memory of past infections. When matching viral sequences invade, Cas proteins recognize and cut the viral DNA. This natural system was adapted for genome editing by combining spacer recognition with various effector proteins.

The restriction-modification system is a bacterial defense mechanism against viral infection. Bacteria produce restriction enzymes that recognize and cut specific DNA sequences. The bacteria's own DNA is protected by methylation at these recognition sites, preventing self-destruction. This system allows bacteria to distinguish between self and foreign DNA, providing protection against bacteriophage infection.

Bacteria use restriction-modification systems as defense against viral infections. When bacteriophage (bacterial virus) DNA enters a bacterial cell, restriction endonucleases recognize and cut the foreign viral DNA. The bacterial genome is protected through methylation at recognition sites, marking it as 'self.' This system distinguishes between bacterial DNA (protected) and viral DNA (destroyed), providing innate immunity to bacterial cells.

Phage therapy offers a promising solution to antibiotic resistance by exploiting evolutionary tradeoffs: instead of using phages that only kill bacteria, researchers now seek phages that target bacterial defense mechanisms (such as efflux pumps that expel antibiotics), forcing bacteria to sacrifice their antibiotic resistance when evolving to escape phage predation; this approach has already been successfully applied in at least 20 hospitalized patients with multidrug-resistant infections.

Phages are viruses that specifically hunt and kill bacteria by injecting their DNA into bacterial cells, causing them to produce more phages until the bacteria burst open; unlike broad-spectrum antibiotics that can harm beneficial bacteria and promote resistance, phages are highly selective, targeting only specific bacterial species, making them promising candidates for treating antibiotic-resistant superbugs as the medical community faces a growing crisis of multidrug-resistant infections.

Phage therapy emerged during the Soviet era with leading centers in Russia and Georgia. The therapy uses bacteriophages (viruses that infect bacteria) to treat bacterial infections, offering an alternative to antibiotics. However, standardization is extremely difficult because bacteria continuously evolve, requiring new phages each year. This creates a cycle where researchers must constantly develop new phage mixtures. Synthetic phages are now produced by extracting genetic material and synthesizing it in laboratories, allowing consistent production without biological cultivation. Phages work by attaching to bacterial cell walls, injecting genetic material, and hijacking bacterial machinery to produce more phages, eventually causing bacterial cell lysis. This creates a rapid, self-propagating treatment that only affects specific bacterial strains.

Bacteriophages are viruses that specifically infect and destroy bacteria, discovered by Felix d'Herelle in the early 20th century. In 1896, Ernest Hankin discovered their natural presence in the Ganges River, where they killed cholera bacteria within 3 hours. Bacteriophages are widely distributed in nature, existing wherever bacteria are present. They function through absolute intracellular parasitism, attaching to bacterial receptors and releasing enzymes that dissolve cell walls. The infection cycle takes 20-40 minutes, during which one bacteriophage produces 100-300 new offspring. Unlike antibiotics, bacteriophages offer significant advantages: they are living organisms with 70-90% sensitivity to bacterial strains, act selectively only on bacteria with specific receptor proteins, and cause no side effects like dysbiosis or fungal infections. They remain effective against antibiotic-resistant bacteria, as resistance requires bacterial mutation and receptor changes, which can be countered by developing new phage groups in just 2-3 days. Phage therapy is used to treat infections caused by E. coli, Staphylococcus, Streptococcus, Pseudomonas, Klebsiella, and pathogens causing dysentery and salmonellosis. It is particularly effective for antibiotic-resistant infections like pseudomembranous colitis caused by Clostridium difficile. The therapy is safe for newborns with inflammatory diseases. However, limitations exist: high selectivity requires precise pathogen identification, and multiple pathogen infections require phage cocktails. Diagnosis involves blood, urine, and swab analysis with bacteriological culture to select effective phages.

Transduction is a mechanism of horizontal gene transfer where bacteriophages (viruses that infect bacteria) transfer bacterial DNA from one bacterium to another. The virus accidentally packages bacterial DNA along with its own genetic material and transfers it to a new host cell during subsequent infections.

Transduction is a genetic recombination process that occurs accidentally through bacteriophages (viruses that infect bacteria). Sometimes bacteriophages accidentally package fragments of bacterial DNA instead of their own viral genetic material. When these modified phages infect other bacterial cells, they inject the bacterial DNA fragment into the new host cell, where it can be integrated into the recipient's DNA, increasing the genetic information of that bacterial cell.

Transduction is a form of horizontal gene transfer mediated by bacteriophages (viruses that infect bacteria). During generalized transduction, a bacteriophage accidentally packages a fragment of bacterial DNA instead of its own viral DNA. When this defective phage infects a new bacterial cell, it delivers the donor DNA fragment to the recipient. This donor DNA may then recombine with the recipient's chromosome, transferring genetic material between bacteria through viral intermediaries.

Transduction is a type of horizontal gene transfer mediated by bacteriophages (viruses that infect bacteria). During viral infection, a bacteriophage injects its DNA into a bacterial cell. Occasionally, bacterial DNA is accidentally packaged into new viral particles instead of viral DNA. When these transducing phages infect other bacterial cells, they deliver bacterial DNA from the original cell. The recipient cell can then incorporate this DNA into its chromosome through homologous recombination, acquiring new genetic traits.

Transduction is a bacterial genetic recombination mechanism where bacteriophages (viruses that infect bacteria) transfer foreign DNA between bacterial cells; during phage assembly, some phage particles accidentally package both viral DNA and bacterial chromosome fragments, which can then be transferred to new host cells, potentially integrating into the recipient's chromosome and providing new functions such as antibiotic resistance or toxin production.